Provided by Tiger Trade Technology Pte. Ltd.

HeartFlow Inc

27.97
+1.154.29%
Post-market: 27.970.00000.00%16:10 EDT
Volume:2.01M
Turnover:54.89M
Market Cap:2.40B
PE:-20.43
High:28.00
Open:26.24
Low:25.78
Close:26.82
52wk High:41.22
52wk Low:20.13
Shares:85.76M
Float Shares:19.17M
Volume Ratio:0.74
T/O Rate:10.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3690
EPS(LYR):-3.1700
ROE:-111.37%
ROA:-16.75%
PB:7.98
PE(LYR):-8.82

Loading ...

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD

GlobeNewswire
·
Dec 19, 2025

Heartflow Inc. Director Jeffrey C. Lightcap Reports Acquisition of Common Shares

Reuters
·
Dec 18, 2025

Heartflow FFRCT Analysis Shows Improved Outcomes and Cost Savings in NHS Study of 90,000 Patients

Reuters
·
Dec 11, 2025

HeartFlow, Inc. (HTFL) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Nov 25, 2025

Heartflow Inc. unveils investor presentation highlighting AI-driven cardiology growth and product strategy

Reuters
·
Nov 24, 2025

HeartFlow, Inc.: Promising Growth with Valuation Concerns Justifying Hold Rating

TIPRANKS
·
Nov 13, 2025

U.S. RESEARCH ROUNDUP-Abbvie, BristolMyers Squibb, Diversified Healthcare

Reuters
·
Nov 13, 2025

HeartFlow, Inc. Reports Robust Q3 2025 Revenue Growth

TIPRANKS
·
Nov 13, 2025

Heartflow Inc : JP Morgan Raises Target Price to $40 From $36

THOMSON REUTERS
·
Nov 13, 2025

Heartflow Q3 Total Revenue $46.3 Million

THOMSON REUTERS
·
Nov 13, 2025

Heartflow Q3 EPS $-1.04

THOMSON REUTERS
·
Nov 13, 2025

Heartflow reports Q3 EPS (27c), consensus (24c)

TIPRANKS
·
Nov 13, 2025

Heartflow sees FY25 revenue view $173M-$173.5M, consensus $165.97M

TIPRANKS
·
Nov 13, 2025

HeartFlow Q3 Adj. EPS $(0.27) Misses $(0.22) Estimate, Sales $46.276M Beat $41.960M Estimate

Benzinga
·
Nov 13, 2025

Heartflow reports Q3 revenue of $46.3 million with net operating loss of $15.1 million

Reuters
·
Nov 13, 2025

Heartflow Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 13, 2025

Heartflow announces data from FISH&CHIPS Study on Heartflow Plaque Analysis

TIPRANKS
·
Nov 10, 2025

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

GlobeNewswire
·
Nov 10, 2025

Heartflow Unveils AI-Driven Plaque Analysis Data Predicting Cardiovascular Outcomes at AHA 2025

Reuters
·
Nov 03, 2025

Why investors are betting big on AI-powered health care

LiveWire
·
Oct 29, 2025